-
IGF2BP1–TUBB4B Signaling in Liver Fibrosis
2026-08-28
The reference study identifies an m6A-dependent IGF2BP1–TUBB4B–FAK axis that promotes hepatic stellate cell activation, proliferation, and migration. Its integrated transcriptomic, RNA-binding, and cellular perturbation strategy provides a mechanistic framework for connecting epitranscriptomic RNA stabilization with fibrogenesis and for designing pathway-level validation studies.
-
Sumatriptan Succinate: Assay Workflows
2026-08-28
Use Sumatriptan as a mechanistic probe across receptor pharmacology, neurogenic inflammation, and oxidative drug-metabolism assays—not only as a migraine research compound. This workflow combines concentration planning, recombinant-enzyme profiling, LC–MS confirmation, and practical troubleshooting for more interpretable serotonergic signaling research.
-
SW033291: 15-PGDH Control for Regeneration
2026-08-27
SW033291 is a potent 15-PGDH inhibitor that elevates endogenous PGE2 and provides a mechanistically defined tool for studying hematopoiesis, tissue repair, and regenerative resilience. New muscle-repair findings during semaglutide-associated weight loss broaden the translational rationale while underscoring the need to validate compound-specific effects across tissues.
-
Sulfamonomethoxine Workflows for Aquaculture Research
2026-08-27
Sulfamonomethoxine (SMM) supports controlled studies of folate-pathway inhibition, veterinary antimicrobial exposure, and aquatic environmental fate. Its value is greatest when formulation, solvent controls, parasite-specific endpoints, and measured concentrations are built into the workflow rather than inferred from antibiotic class alone.
-
BI 2536 for Reliable PLK1 Assays
2026-08-26
Learn how BI 2536 (SKU A3965) can support better-designed cell viability, proliferation, cytotoxicity, and cell-cycle experiments. This practical guide connects PLK1 biology with stock preparation, endpoint selection, data interpretation, and vendor evaluation.
-
Deferoxamine Mesylate: Iron Stress Workflow
2026-08-26
Deferoxamine mesylate provides a practical way to manipulate labile iron, oxidative stress, and hypoxia signaling in cell and tissue models. This workflow guide shows how to use it as a mechanistic control for ferroptosis, HIF-1α stabilization, wound healing promotion, and cancer-related assays without confusing chelation effects with direct cytotoxicity.
-
AICAR Phosphate: AMPK to Translational Apoptosis
2026-08-25
A mechanistic and strategic guide to using AICAR phosphate (Acadesine) to connect AMPK signaling with mitochondrial apoptosis in B-CLL research, while assessing how emerging neuroimmune findings may inform—but not yet validate—future translational applications.
-
CHIR 99021: Tuning Organoid Stemness
2026-08-25
A translational framework for using CHIR 99021 trihydrochloride to interrogate GSK-3 biology, tune organoid self-renewal and differentiation, and connect stem-cell systems with insulin signaling and metabolic disease research.
-
Cyclo (-RGDfC): From Binding Probe to Assay Design
2026-08-24
Cyclo (-RGDfC) is a cyclic RGD probe for αvβ3 integrin research. This guide connects receptor targeting with assay design, endpoint selection, and lessons from canine osteosarcoma viability research.
-
RITA (NSC 652287): From p53 Mechanism to Translation
2026-08-24
RITA (NSC 652287) offers translational researchers a way to connect MDM2-p53 pathway activation, DNA cross-link biology, cell-death measurement, and tumor xenograft evidence. This thought-leadership framework explains how to evaluate its reported activity without confusing growth inhibition with cell killing or preclinical promise with clinical validation.
-
Myriocin Reverses dAGE-Driven Metabolic Dysfunction
2026-08-23
This 2025 Nutrients study identifies sphingolipid synthesis inhibition as a potential strategy for correcting diet-derived advanced glycation end product–associated metabolic dysfunction. In mice, Myriocin improved body-weight gain, hepatic steatosis, glucose handling, circulating lipids, mitochondrial biogenesis, and adipose thermogenesis through coordinated AMPK–PGC1α signaling.
-
Doxorubicin Hydrochloride: Practical Assay Workflows
2026-08-22
Build reproducible Doxorubicin hydrochloride experiments across cancer-cell screening, apoptosis assay design, dual-loaded liposome characterization, and cardiotoxicity models. This guide combines dose-planning, analytical separation, controls, and troubleshooting so Adriamycin HCl data remain interpretable from bench assay to preclinical study.
-
Quercetin Beyond PI3K: From Apoptosis to Ferroptosis
2026-08-22
Quercetin is more than a familiar dietary flavonoid: it is a mechanistically broad research tool linking PI3K signaling, mitochondrial apoptosis, inflammation, lipid peroxidation, and ferroptosis. A recent Wilson disease study provides a valuable translational case study, showing how quercetin may protect injured liver tissue by engaging the ACSL4/LPCAT3/ALOX15 axis. This article translates those findings into a rigorous framework for cancer research, liver injury models, pathway validation, and reproducible compound deployment.
-
Norovirus Co-opts NINJ1 for Selective NS1 Secretion
2026-08-21
Song et al. show that murine norovirus uses the host membrane-rupture factor NINJ1 to release the viral immune-modulatory protein NS1 through an unconventional secretion route. The study combines CRISPR screening, caspase-3 perturbation, microscopy, viral-protein mutagenesis, and mouse infection experiments to connect selective NS1 release with enteric infection.
-
Diclofenac in Human Intestinal Organoid Workflows
2026-08-20
Learn how to use Diclofenac as a non-selective COX inhibitor in human iPSC-derived intestinal organoids while separating intestinal exposure, metabolism, and prostaglandin-linked pharmacodynamics. The workflow combines practical dosing, assay controls, and troubleshooting guidance for translational inflammation and pharmacokinetic studies.